Aclaris Therapeutics, Inc. (0H8T.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
19.09-9.53 (-33.31%)
At close: 2:44PM BST
| Previous close | 28.62 |
| Open | 27.62 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 27.62 - 27.62 |
| 52-week range | 27.62 - 27.62 |
| Volume | 400 |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.20 |
| Earnings date | 25 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Aclaris Therapeutics (NASDAQ:ACRS) Weighed On By Its Debt Load?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
- Simply Wall St.
How Much Does Aclaris Therapeutics' (NASDAQ:ACRS) CEO Make?
Neal Walker became the CEO of Aclaris Therapeutics, Inc. (NASDAQ:ACRS) in 2012, and we think it's a good time to look...
- Simply Wall St.
Could The Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Ownership Structure Tell Us Something Useful?
The big shareholder groups in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) have power over the company. Institutions often...
© 2021 Verizon Media. All rights reserved.
